Radiocontrast medium induces histamine release in association with upregulation of miR‑19a‑3p and miR‑362‑3p expression
- Authors:
- Published online on: April 19, 2024 https://doi.org/10.3892/br.2024.1780
- Article Number: 93
-
Copyright: © Chang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
In Taiwan, the use of radiocontrast medium for clinical image diagnosis recently surpassed one million times and the overall prevalence of radiocontrast hypersensitivity was ~7%. A microRNA (miRNA/miRs) is a small non‑coding RNA molecule that mostly plays a suppressor role in cells. However, the roles of miRNA expression in radiocontrast‑induced mast cells activation remains to be elucidated. The aim of the present study was to investigate the role of miRNA on radiocontrast‑induced mast cell activation. Computed tomography radiocontrast, ultravist and mouse mast cell line, P815, were used in the present study. Cell viability was detected by CCK‑8 experiment. Levels of histamine and β‑hexosaminidase were measured by ELISA. miRNA expression was detected by miRNA sequencing and reverse transcription‑quantitative PCR. The results showed that ultravist could increase histamine release and reduce intracellular β‑hexosaminidase levels of mast cells. A total of 102 miRNAs could be significantly upregulated by ultravist stimulation. Selected candidate miRNAs for the validation included miR‑19a‑3p and miR‑362‑3p which were also increased expression following stimulation with ultravist. In conclusion, ultravist could induce mast cell activation through upregulation of miR‑19a‑3p and miR‑362‑3p. Thus, miR‑19a‑3p and miR‑362‑3p could be promising candidates for development as novel targets for preventing radiocontrast‑induced allergy in the future.
